In conclusion, our findings (Fig. 6I) identify a novel regulatory signaling axis, LINC01554/G3BP2/HDGF, that facilitates ESCC metastasis, which may provide rational strategies for developing potential biomarkers and therapeutic targets for ESCC. The gene discussed is G3BP2; the disease is esophageal squamous cell carcinoma.